Table 2.
Knowledge of filariasis in the community
| Variables | Responses | Male (N = 334) % (95% CI) | Female (N = 357) % (95% CI) | Total (N = 691) % (95% CI) |
|---|---|---|---|---|
| What is filariasis? |
Elephantiasis |
61.6(65.4–74.8) |
70.3(65.4–74.8) |
67.8(64.3–71.3) |
| Lymphedema and elephantiasis |
32.5(27.7–37.5) |
29.1(24.6–34.0) |
31.7(28.3–35.2) |
|
| Do not know |
0.3(0.01–1.4) |
0.56(0.1–1.70) |
0.43(0.11–1.17) |
|
| Mode of transmission for filariasis? |
Mosquito bite |
90.4(86.9–93.2) |
85.4(81.5–88.8) |
87.8(85.2–90.1) |
| Hereditary/contagious |
8.7(6.0–12.0) |
13.1(9.9–16.5) |
11(8.8–13.5) |
|
| Do not know |
0.9(0.22–2.42) |
1.4(0.5–3.07) |
1.15(0.54–2.2) |
|
| Most common symptoms |
Swelling of limbs |
60.4(55.2–65.7) |
34.0(29.1–39.0) |
46.7(43.0–50.5) |
| Fever and swelling |
38.6(33.5–44.0) |
65.2(60.2–70.0) |
52.4(48.6–56.1) |
|
| Do not know |
0.9(0.22–2.42) |
1.12(0.35–2.68) |
1.0(0.44–2.0) |
|
| Treatment |
Medicine |
90.1(86.5–93.0) |
85.0(80.5–88.0) |
87.3(84.6–89.6) |
| Not curable |
8.9(6.25–12.42) |
13.4(10.2–17.3) |
11.3(9.1–13.8) |
|
| Do not know |
0.9(0.22–2.42) |
1.96(0.9–3.8) |
1.4(0.7–2.56) |
|
| Knowledge regarding the distribution of filarial tablets for prevention |
Yes |
95.5(92.9–97.4) |
90.5(87.0–93.2) |
92.9(90.8–94.6) |
| No |
4.5(2.63–7.13) |
9.5(6.8–12.9) |
7.1(5.35–9.20) |
|
| Do you consider yourself to be at risk? | Yes |
86.5(82.5–89.9) |
80.9(76.6–84.7) |
83.6(80.7–86.3) |
| No |
12.3(9.0–16.13) |
17.08(13.4–21.2) |
14.7(12.2–17.5) |
|
| Do not know | 1.2(0.4–2.9) | 1.96(0.9–3.8) | 1.6(0.83–2.75) |